CLASS II Device recall · Reported 26 Jan 2022 · FDA Enforcement Report

Aries HSV 1&2 Assay recalled by Luminex

Luminex is recalling Aries HSV 1&2 Assay, distributed nationwide in the US. The recall was initiated on 16 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot number AB1703A
Quantity recalled296 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0498-2022
FDA event ID
89303
Recalling firm
Luminex, Austin, TX
Classification
Class II
Status
Terminated
Recall initiated
16 Apr 2021
FDA classified
14 Jan 2022
Reported
26 Jan 2022
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Packaging Defects

Timeline

16 Apr 2021Recall initiated by company
14 Jan 2022Classified by FDA+273 days
26 Jan 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Impacted lot may leak inside the ARIES instrument.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

ARIES HSV 1&2 Assay, Part Number/REF 50-10017

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of Alabama, California, Georgia, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New Mexico, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin and the country of Taiwan.

Nationwide AlabamaCaliforniaGeorgiaKansasKentuckyLouisianaMassachusettsMichiganMinnesotaMissouriNebraskaNew JerseyNew MexicoOhioOklahomaOregonPennsylvaniaTennesseeTexasVirginia

Questions about this recall

Why was it recalled?

Impacted lot may leak inside the ARIES instrument.

Which lots are affected?

Lot number AB1703A

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of Alabama, California, Georgia, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New Mexico, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin and the country of Taiwan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Luminex

All 39

Other Test Kits & Diagnostics recalls

All 2,661